BCPC

Balchem Corp

Industrial/Transportation


Presented:07/08/2015
Price:$53.49
Cap:$1.66B
Current Price:$172.01
Cap:$5.58B

Presented

Date07/08/2015
Price$53.49
Market Cap$1.66B
Ent Value$1.93B
P/E Ratio28.5x
Book Value$13.24
Div Yield0.56%
Shares O/S31.09M
Ave Daily Vol168,841
Short Int4.85%

Current

Price$172.01
Market Cap$5.58B
Balchem Corp. engages in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the U.S. and internationally. The company operates its business through the following segments: Specialty Products; Food, Pharma & Nutrition; and Animal Nutrition & Health. The Specialty Products segment provides specialty-packaged chemicals for use in healthcare and other industries. The Food, Pharma & Nutrition segment provides microencapsulation solutions to a variety of applications in food, pharmaceutical and nutritional ingredients to enhance performance of nutritional fortification, processing, mixing, and packaging applications and shelf-life. The Animal Nutrition & Health segment provides the animal nutrition and health markets with products derived from its microencapsulation, chelation, and basic choline chloride technologies. In this segment, the company markets REASHURE Choline, an encapsulated choline product that improves health and production in transition and early lactating dairy cows. It also markets NITROSHURETM, an encapsulated urea supplement for lactating dairy cows, which allows for greater flexibility in feed rations for dairy nutritionists and producers, and NIASHURETM, a microencapsulated niacin product, to help fight heat stress in animals. In addition, the company manufactures, sells and distributes chelated mineral supplements for use in animal feed, utilizing its proprietary chelation technology for enhanced nutrient absorption for various species of production and companion animals. Balchem was founded in January 1967 and is headquartered in New Hampton, NY.

Publicly traded companies mentioned herein: Balchem Corp (BCPC)

Highlights

At first glance, Balchem (BCPC) appears to have no connection to the energy sector. In its own words, the company “engages in the development, manufacture, and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the United States and internationally”. However, the presenter is short the stock at present levels (~$54), and cited a favorable risk/ reward based on the 20% of BCPC’s business that is exposed to energy (choline is used for clay stabilization in fracking) and the potential for growth to return to more normalized levels (closer to GDP growth) as its energy business slows and previous M&A activity is lapped year-over-year.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.